Medicare

Electronic Caregiver Announces Breakthrough Results from National Medicare Test of Addison Care(R), Demonstrating Unprecedented Patient Engagement, High Reliability, and Scalability for Nationwide Rollout

Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway

Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida's Department of Surgery,...

Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection

Management to host conference call at 8:00 AM Eastern time on Thursday, November 13, 2025Toronto, Ontario and Chicago, Illinois--(Newsfile Corp....

Lightbeam Health Solutions Recognized as the Winner of 2025 Microsoft Healthcare and Life Sciences Partner of the Year

DALLAS, Nov. 12, 2025 /PRNewswire/ -- Lightbeam Health Solutions, the proven, AI-enabled solutions and services leader in population health management, today announced...

States Can Automate Medicaid Community Engagement Verification With CITIZ3N’s VERIFY Solution Ahead of December Deadline

Multistep framework improves eligibility verification process for enrollees, addresses states' compressed timeline to meet federal community engagement mandate by December...

Get Well, a leader in patient engagement software, and RhythmX AI, a leader in AI-powered precision care, will combine to form GW RhythmX to usher in the next generation of precision care

Precise Introduces the First Unified Behavioral Health Operating System BOS Servicing the Complete Care Continuum

Designed by clinicians for clinicians, BOS improves clinical outcomes, financial performance, and value-based care results. LOS ANGELES, CA / ACCESS...

Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet

Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in patients undergoing total knee replacement...

error: Content is protected !!